Skip to content
Round-UpReport

CLDI

Calidi Biotherapeutics, Inc.

1-for-16 reverse split, effective Jul 31, 2026.

Ratio
1-for-16
Effective date
Jul 31, 2026
Last day to buy
Jul 30, 2026

Prior NYSE session before the effective date. Calculated, not a filing field.

Be on record by
Filing does not state a record date
Fractional shares
Rounds up
Form
8-K

Filed Jul 31, 2026

Split Adjustment; Treatment of Fractional Shares On the Effective Date, the total number of shares of Common Stock held by each stockholder of the Company were exchanged for the number of shares of Common Stock equal to the number of issued and outstanding shares of Common Stock held by each such stockholder immediately prior to the Reverse Stock Split, divided by sixteen (16), with such resulting number of shares rounded up to the nearest whole share.

From the filing, on fractional shares.

Read the SEC filing

Broker reports

No approved reports yet. If your broker handled this split, send a report.

New round-up filings and broker reports. Unsubscribe any time.